SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Hyytinen Mila)
 

Sökning: WFRF:(Hyytinen Mila) > Recruitment and ret...

Recruitment and retention of participants for an international type 1 diabetes prevention trial : a coordinators' perspective.

Franciscus, Margaret (författare)
Department of Pediatric Medicine, University of Pittsburgh, Pittsburgh, PA, USA
Nucci, Anita (författare)
Department of Nutrition, Georgia State University, Atlanta, GA, USA
Bradley, Brenda (författare)
Children’s Hospital of Eastern Ontario Research Institute, Ottawa, ON, Canada
visa fler...
Suomalainen, Heli (författare)
Institute of Clinical Medicine, University of Helsinki, Helsinki, Finland
Greenberg, Ellen (författare)
Naomi Berrie Diabetes Center, Columbia University, New York, USA
Laforte, Diane (författare)
Montreal Children’s Hospital, Montreal, QC, Canada
Kleemola, Paivi (författare)
Institute of Clinical Medicine, University of Helsinki, Helsinki, Finland
Hyytinen, Mila (författare)
Institute of Clinical Medicine, University of Helsinki, Helsinki, Finland
Salonen, Marja (författare)
Institute of Clinical Medicine, University of Helsinki, Helsinki, Finland
Martin, Mary Jean (författare)
Department of Endocrinology, Hospital for Sick Children, Toronto, ONT, Canada
Catte, Daniel (författare)
University of Manitoba, Winnipeg, MB, Canada
Catteau, Jacki (författare)
Department of Endocrinology and Diabetes, The Children’s Hospital at Westmead, Sydney, NSW, Australia
visa färre...
 (creator_code:org_t)
2013-11-11
2014
Engelska.
Ingår i: Clinical Trials. - : SAGE Publications. - 1740-7745 .- 1740-7753. ; 11:2, s. 150-8
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • BACKGROUND: The Trial to Reduce Insulin Dependent Diabetes Mellitus in the Genetically at Risk (TRIGR) is the first multicenter international type 1 diabetes (T1D) prevention trial to be undertaken. A unique feature of TRIGR has been recruitment of eligible pregnant women and enrollment of newborns for long-term follow-up assessments.PURPOSE: Our purpose is to summarize the recruitment and retention strategies used to conduct TRIGR from the perspective of the study coordinators.METHODS: TRIGR was designed to test whether weaning to formula containing hydrolyzed versus intact cow's milk protein would be efficacious in decreasing risk for development of T1D-associated autoantibodies and T1D among infants identified to be at increased risk for T1D based on their human leukocyte antigen (HLA) profile and family history. Multiple strategies tailored to local issues were required to enroll and follow the target number of infants.RESULTS: This study was conducted in the United States, Canada, Australia, and 12 countries in Europe. Of the 5606 mothers registered worldwide, 5000 of their infants were randomized. Of these, 2159 were HLA eligible and enrolled in the 8-month intervention and 10-year follow-up phases of this study. The TRIGR study met the accrual goal after 4.7 years of recruitment, 2.7 years longer than projected initially. Challenges included difficulty in finding fathers with T1D, a higher than expected rate of premature delivery among T1D mothers, and implementation of new privacy regulations mid-trial. The majority of participants were recruited from primary care antenatal clinics located near the study centers and from a general hospital or pediatric center that was affiliated with a TRIGR Study center. Internet and magazine advertisements were found to be useful for recruitment of families. Alternative follow-up strategies are offered to families who wish to reduce or discontinue participation.LIMITATIONS: Our experience is limited to a single international multicenter trial.CONCLUSIONS: TRIGR coordinators played key roles in the recruitment and intervention periods and continue to be instrumental in retaining families and children during the 10-year follow-up period for each child.

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy